CAS: 22353-38-4; 3-Chloro-2-Hydroxy-5-Nitropyridine

该化合物是一种环环生物化合物,其特点是用氯原子和硝基子组取代了环状环状环状物,这些功能组的存在具有独特的化学特性,包括增加反应力和各种化学变异的可能性.这种化合物一般在室温中呈现为固体,在极地有机溶剂中可以溶解.其分子结构表明,它可能由于硝基子组的电子提取性质而参与核分裂性替代反应,这可以增强氮的电荷.此外,氯原子在某些反应中可以作为离开的组.3-Crolono-5-nitro-2(H)-pyridrinone也可能表现出生物活动,从而引起对药物研究的兴趣.安全数据表明,它与许多硝基化合物一样,由于潜在的毒性和环境危害而应当受到谨慎处理.适当的储存和处置方法对于减轻其使用的风险至关重要.

结构式图片

相似化合物

21427-61-2 850663-54-6 198268-98-3

欧盟法规

C&L通报

上下游产品

CAS号5418-51-9 2-羟基-5-硝基吡啶 | CAS号22353-40-8 5-硝基-2,3-二氯吡啶 | CAS号22353-35-1 2-氨基-3-氯-5-硝基吡啶 | CAS号4214-76-0 2-氨基-5-硝基吡啶 | CAS号22353-41-9 2-溴-3-氯-5-硝基吡啶 | CAS号22353-40-8 5-硝基-2,3-二氯吡啶 | CAS号130284-52-5 5-氨基-2-溴-3-氯吡啶 | CAS号98121-41-6 5, 6-二氯-3-氨基吡啶 | CAS号110860-92-9 2,3-二氯-5-羟基吡啶 | CAS号130284-56-9 2-溴-3-氯-5-羟基吡啶

合成工艺路线路线简述

  • 合成目标产物 3-Chloro-2-Hydroxy-5-Nitropyridine 主要起始原料 2-Hydroxy-5-Nitropyridine
  • (文献来源)合成步骤主要原料 2-Hydroxy-5-Nitropyridine
📜2-羟基-5-硝基吡啶置于盐酸,Potassium Chlorate体系中,化学反应 0.25H,以93%的收率获得5-硝基-2-羟基-3-氯吡啶
参考文献:Chemistry Of 3-Hydroxypyridine Part 2: Synthesis Of 5,6-Dihalo-3-Hydroxypyridines
标题:Chemistry Of 3-Hydroxypyridine Part 2: Synthesis Of 5,6-Dihalo-3-Hydroxypyridines
摘要:本文介绍了从市售的 2-Hydroxy-5-Nitropyridine 开始,多步骤合成迄今未知的 5,6-二卤-3-羟基吡啶的方法.此外,还探讨了廉价的 2-氨基甲基呋喃(糠胺)在新颖的两步法中制备标题化合物的适用性.
Doi:10.1055/s-1990-26919

海关参考信息

专利信息


专利号:US-5144038-A
优先权日:1990-07-17
标题:Process for the production of 2-hydroxy-3-halo-5-nitropyridines
发明人:WORSCH DETLEV
权利人:LONZA AG
摘要:A process for the production of 2-hydroxy-3-halo-5-nitropyridines, in which a 5-halo-6-hydroxynicotinic acid is nitrated in the end product. The resultant pyridines form valuable intermediate products for active ingredient synthesis.

专利号:US-9815842-B2
优先权日:2014-05-28
标题 :Pyrazolo pyrimidine derivatives and their use as MALT1 inhibitors
发明人:SOLDERMANN CAROLE PISSOT; QUANCARD JEAN; SCHLAPBACH ACHIM; SIMIC OLIVER; TINTELNOT-BLOMLEY MARINA; ZOLLER THOMAS
权利人:SOLDERMANN CAROLE PISSOT; QUANCARD JEAN; SCHLAPBACH ACHIM; SIMIC OLIVER; TINTELNOT-BLOMLEY MARINA; ZOLLER THOMAS; NOVARTIS AG
摘要:The present invention describes new pyrazolo-pyrimidine derivatives which are generally interacting with MALT1 proteolytic and/or autoproteolytic activity, and in particular which may inhibit said activity. The present invention further describes the synthesis of said new pyrazolo-pyrimidine derivatives, their use as a medicament, especially by interacting with MALT1 proteolytic and/or autoproteolytic activity.

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式

合成参考文献


参考文献:10.1007/s00044-013-0814-y
摘要:Deka N, Uravane M, Anthony J, Bhumra SK, Nair A, B-Rao C, Patel D, Sivaramakrishnan H. Design and synthesis of non-TZD peroxisome proliferator-activated receptor γ (PPARγ) modulator. Medicinal Chemistry Research. 2013 Oct 10;23(4):2150–9. doi: 10.1007/s00044-013-0814-y.
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知